Strawberry phytochemicals inhibit azoxymethane/dextran sodium sulfate-induced colorectal carcinogenesis in Crj: CD-1 mice

Nutrients

Volumn 7, Issue 3, 2015, Pages 1696-1715

  Shi, Ni ^a   Clinton, Steven K ^a,b   Liu, Zhihua ^c   Wang, Yongquan ^c   Riedl, Kenneth M ^a,b   Schwartz, Steven J ^a,b   Zhang, Xiaoli ^a   Pan, Zui ^a   Chen, Tong ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c CANCER HOSPITAL   (China)

Author keywords

Chemoprevention; Colitis; Colorectal cancer; Phytochemicals; Strawberry

Indexed keywords

3 NITROTYROSINE; AZOXYMETHANE; DEXTRAN SULFATE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROSTAGLANDIN E2; PROTEIN KINASE B; STRAWBERRY EXTRACT; UNCLASSIFIED DRUG; ANTHOCYANIN; ANTINEOPLASTIC AGENT; AUTACOID; ELLAGIC ACID; FLAVONOL DERIVATIVE; PLANT MEDICINAL PRODUCT;

ADENOCARCINOMA; ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CD-1 MOUSE; CHEMOPROPHYLAXIS; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORIMETRY; CONTROLLED STUDY; DIET; DRUG BIOAVAILABILITY; DYSPLASIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PHARMACOKINETIC PARAMETERS; PHOSPHORYLATION; PHYTOCHEMISTRY; REAL TIME POLYMERASE CHAIN REACTION; STRAWBERRY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; COLORECTAL NEOPLASMS; FRAGARIA; FRUIT; FUNCTIONAL FOOD; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHYTOTHERAPY;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTHOCYANINS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZOXYMETHANE; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; ELLAGIC ACID; FLAVONOLS; FRAGARIA; FRUIT; FUNCTIONAL FOOD; INFLAMMATION MEDIATORS; MALE; MICE, INBRED ICR; PHYTOCHEMICALS; PHYTOTHERAPY;

EID: 84982678203     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7031696     Document Type: Article

References (54)

1. American Cancer Society. Cancer Facts and Figures; American Cancer Society: Atlanta, GA, USA, 2012; p. 10.
2. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective; AICR: Washington, DC, USA, 2007; pp. 1-537.
3. Azer, S.A. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Eur. J. Gastroenterol. Hepatol. 2013, 25, 271-281.
4. Feagins, L.A.; Souza, R.F.; Spechler, S.J. Carcinogenesis in IBD: Potential targets for the prevention of colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 2009, 6, 297-305.
5. Giampieri, F.; Tulipani, S.; Alvarez-Suarez, J.M.; Quiles, J.L.; Mezzetti, B.; Battino, M. The strawberry: Composition, nutritional quality, and impact on human health. Nutrition 2012, 28, 9-19.
6. Basu, A.; Nguyen, A.; Betts, N.M.; Lyons, T.J. Strawberry as a functional food: An evidence-based review. Crit. Rev. Food Sci. Nutr. 2014, 54, 790-806.
7. Casto, B.C.; Knobloch, T.J.; Galioto, R.L.; Yu, Z.; Accurso, B.T.; Warner, B.M. Chemoprevention of oral cancer by lyophilized strawberries. Anticancer Res. 2013, 33, 4757-4566.
8. Somasagara, R.R.; Hegde, M.; Chiruvella, K.K.; Musini, A.; Choudhary, B.; Raghavan, S.C. Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in mice. PLoS One 2012, 7, e47021.
9. Balansky, R.; Ganchev, G.; Iltcheva, M.; Kratchanova, M.; Denev, P.; Kratchanov, C.; Polasa, K.; D’Agostini, F.; Steele, V.E.; de Flora, S. Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke. Int. J. Cancer 2012, 131, 1991-1997.
10. Carlton, P.S.; Kresty, L.A.; Siglin, J.C.; Morse, M.A.; Lu, J.; Morgan, C.; Stoner, G.D. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 2001, 22, 441-446.
11. Chen, T.; Yan, F.; Qian, J.; Guo, M.; Zhang, H.; Tang, X.; Chen, F.; Stoner, G.D.; Wang, X. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev. Res. 2012, 5, 41-50.
12. Yarom, N.; Jonker, D.J. The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer. Discov. Med. 2011, 11, 95-105.
13. Wang, M.Y.; Lu, K.V.; Zhu, S.; Dia, E.Q.; Vivanco, I.; Shackleford, G.M.; Cavenee, W.K.; Mellinghoff, I.K.; Cloughesy, T.F.; Sawyers, C.L.; et al. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res. 2006, 66, 7864-7869.
14. Nakano, H.; Shindo, M.; Sakon, S.; Nishinaka, S.; Mihara, M.; Yagita, H.; Okumura, K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 1998, 95, 3537-3542.
15. Johnson, G.L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912.
16. Huang, X.L.; Xu, J.; Zhang, X.H.; Qiu, B.Y.; Peng, L.; Zhang, M.; Gan, H.T. PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm. Res. 2011, 60, 727-734.
17. Greten, F.R.; Eckmann, L.; Greten, T.F.; Park, J.M.; Li, Z.W.; Egan, L.J.; Kagnoff, M.F.; Karin, M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118, 285-296.
18. Kojima, M.; Morisaki, T.; Sasaki, N.; Nakano, K.; Mibu, R.; Tanaka, M.; Katano, M. Increased nuclear factor-κB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 2004, 24, 675-681.
19. Chen, T.; Hwang, H.; Rose, M.E.; Nines, R.G.; Stoner, G.D. Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: Down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res. 2006, 66, 2853-2859.
20. Stoner, G.D. Foodstuffs for preventing cancer: The preclinical and clinical development of berries. Cancer Prev. Res. 2009, 2, 187-194.
21. Gu, J.; Ahn-Jarvis, J.H.; Riedl, K.M.; Schwartz, S.J.; Clinton, S.K.; Vodovotz, Y. Characterization of black raspberry functional food products for cancer prevention human clinical trials. J. Agric. Food Chem. 2014, 62, 3997-4006.
22. Giusti, M.M.; Rodríguez-Saona, L.E.; Wrolstad, R.E. Molar absorptivity and color characteristics of acylated and non-acylated pelargonidin-based anthocyanins. J. Agric. Food Chem. 1999, 47, 4631-4637.
23. Gasperotti, M.; Masuero, D.; Vrhovsek, U.; Guella, G.; Mattivi, F. Profiling and accurate quantification of Rubus ellagitannins and ellagic acid conjugates using direct UPLC-Q-TOF HDMS and HPLC-DAD analysis. J. Agric. Food Chem. 2010, 58, 4602-4616.
24. Riddell, R.H.; Goldman, H.; Ransohoff, D.F.; Appelman, H.D.; Fenoglio, C.M.; Haggitt, R.C.; Ahren, C.; Correa, P.; Hamilton, S.R.; Morson, B.C. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum. Pathol. 1983, 14, 931-968.
25. Pascal, R.R. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal carcinomas. Hum. Pathol. 1994, 25, 1160-1171.
26. Boivin, G.P.; Washington, K.; Yang, K.; Ward, J.M.; Pretlow, T.P.; Russell, R.; Besselsen, D.G.; Godfrey, V.L.; Doetschman, T.; Dove, W.F.; et al. Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 2003, 124, 762-777.
27. Ghia, J.E.; Blennerhassett, P.; Kumar-Ondiveeran, H.; Verdu, E.-F.; Collins, S.M. The vagus nerve: A tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006, 131, 1122-1130.
28. Yasui, Y.; Suzuki, R.; Miyamoto, S.; Tsukamoto, T.; Sugie, S.; Kohno, H.; Tanaka, T. A lipophilic statin, pitavastatin, suppresses inflammation-associated mouse colon carcinogenesis. Int. J. Cancer 2007, 121, 2331-2339.
29. Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6, 65-70.
30. Määttä-Riihinen, K.R.; Kamal-Eldin, A.; Mattila, P.H.; González-Paramás, A.M.; Törrönen, A.M. Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J. Agric. Food Chem. 2004, 52, 4477-4486.
31. Giampieri, F.; Alvarez-Suarez, J.M.; Battino, M. Strawberry and human health: Effects beyond antioxidant activity. J. Agric. Food Chem. 2014, 62, 3867-3876.
32. Forbes-Hernández, T.Y.; Giampieri, F.; Gasparrini, M.; Mazzoni, L.; Quiles, J.L.; Alvarez-Suarez, J.M.; Battino, M. The effects of bioactive compounds from plant foodson mitochondrial function: A focus on apoptotic mechanisms. Food Chem. Toxicol. 2014, 68, 154-182.
33. Kubotaa, M.; Hosoyaa, T.; Fukumotob, S.; Miyagic, T.; Kumazawaa, S. Anti-melanogenic compounds in Rubus croceacanthus. J. Berry Res. 2014, 4, 127-135.
34. Schantz, M.; Moh, C.; Baum, M.; Richling, E. Antioxidative efficiency of an anthocyaninrich bilberry extract in the human colon tumor cell lines Caco-2 and HT-29. J. Berry Res. 2010, 1, 25-33.
35. Zikri, N.N.; Riedl, K.M.; Wang, L.S.; Lechner, J.; Schwartz, S.J.; Stoner, G.D. Blackraspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells. Nutr. Cancer 2009, 6, 816-826.
36. Long, N.; Suzuki, S.; Sato, S.; Naiki-Ito, A.; Sakatani, K.; Shirai, T.; Takahashi, S. Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci. 2013, 104, 298-303.
37. Filipiak, K.; Hidalgo, M.; Silvan, J.M.; Fabre, B.; Carbajo, R.J.; Pineda-Lucena, A.; Ramos, A.; de Pascual-Teresa, B.; de Pascual-Teresa, S. Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action. Food Funct. 2014, 5, 381-389.
38. Bazylko, A.; Piwowarski, J.P.; Filipek, A.; Bonarewicz, J.; Tomczyk, M. In vitro antioxidant and anti-inflammatory activities of extracts from Potentilla recta and its main ellagitannin, agrimoniin. J. Ethnopharmacol. 2013, 149, 222-227.
39. Hämäläinen, M.; Nieminen, R.; Asmawi, M.Z.; Vuorela, P.; Vapaatalo, H.; Moilanen, E. Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages. Planta Med. 2011, 77, 1504-1511.
40. Brown, E.M.; Latimer, C.; Allsopp, P.; Ternan, N.G.; McMullan, G.; McDougall, G.J.; Stewart, D.; Crozier, A.; Rowland, I.; Gill, C.I. In Vitro and in Vivo models of colorectal cancer: Antigenotoxic activity of berries. J. Agric. Food Chem. 2014, 62, 3852-3866.
41. Zackular, J.P.; Baxter, N.T.; Iverson, K.D.; Sadler, W.D.; Petrosino, J.F.; Chen, G.Y.; Schloss, P.D. The gut microbiome modulates colon tumorigenesis. Mbio 2013, 4, e00692-13.
42. Clapper, M.L.; Cooper, H.S.; Chang, W.C. Dextran sulfate sodium-induced colitis-associated neoplasia: A promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin. 2007, 28, 1450-1459.
43. Tanaka, T.; Kohno, H.; Suzuki, R.; Yamada, Y.; Sugie, S.; Mori, H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003, 94, 965-973.
44. Corn, B.W.; Kovner, F.; Bek, S.; Wexler, I.; Lifschit, S.B.; Seger, R. ERK signaling in colorectal cancer: A preliminary report on the expression of phosphorylated ERK and the effects of radiation therapy. Am. J. Clin. Oncol. 2008, 31, 255-258.
45. Pikarsky, E.; Porat, R.M.; Stein, I.; Abramovitch, R.; Amit, S.; Kasem, S.; Gutkovich-Pyest, E.; Urieli-Shoval, S.; Galun, E.; Ben-Neriah, Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431, 461-466.
46. Wang, S.; Liu, Z.; Wang, L.; Zhang, X. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell. Mol. Immunol. 2009, 6, 327-334.
47. Taketo, M.M. COX-2 and colon cancer. Inflamm. Res. 1998, 47, S112-S116.
48. Jaiswal, M.; LaRusso, N.F.; Gores, G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: Linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G626-G634.
49. Kaviani, A.; Ohta, M.; Itani, R.; Sander, F.; Tarnawski, A.S.; Sarfeh, I.J. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J. Gastrointest. Surg. 1997, 1, 371-376.
50. Sands, B.E.; Tremaine, W.J.; Sandborn, W.J.; Rutgeerts, P.J.; Hanauer, S.B.; Mayer, L.; Targan, S.R.; Podolsky, D.K. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study. Inflamm. Bowel Dis. 2001, 7, 83-88.
51. Zhou, B.R.; Zhang, J.A.; Zhang, Q.; Permatasari, F.; Xu, Y.; Wu, D.; Yin, Z.Q.; Luo, D. Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1β, and tumor necrosis factor-α via a NF-κB-dependent mechanism in HaCaT keratinocytes. Med. Inflamm. 2013, 2013, 530429.
52. Peddareddigari, V.G.; Wang, D.; DuBois, R.N. The Tumor Microenvironment in Colorectal Carcinogenesis. Cancer Microenviron. 2010, 3, 149-166.
53. Janakiram, N.B.; Mohammed, A.; Rao, C.V. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev. 2011, 30, 507-523.
54. Half, E.; Arber, N. Colon cancer: Preventive agents and the present status of chemoprevention. Expert Opin. Pharmacother. 2009, 10, 211-219.